Answers are grounded in this paper and cite their sources.
PROBLEM IDENTIFICATION: The use of a decision aid (DA) for women facing the decision of contralateral prophylactic mastectomy (CPM) is limited. This article aimed to examine the literature for studies testing a DA for patients diagnosed with unilateral breast cancer considering CPM. LITERATURE SEARCH: A comprehensive search was conducted in CINAHL®, Ovid MEDLINE®, PubMed®, Web of Science, PsycINFO®, and Cochrane Library databases from 2017 to 2024. DATA EVALUATION: The studies were assessed for relevance in testing a patient DA for CPM in patients diagnosed with unilateral breast cancer. Studies were evaluated using the Mixed Methods Appraisal Tool, version 2018. SYNTHESIS: Five studies met inclusion criteria. These studies included one pre-/postassessment cohort pilot study, one randomized controlled trial, two mixed-methods studies, and one qualitative study. Studies included 370 patients and 50 clinicians in the breast oncology setting. IMPLICATIONS FOR PRACTICE: Oncology nurses can play a key role in advocating for shared decision-making for patients considering CPM. Additional testing of a DA for patients diagnosed with unilateral breast cancer considering CPM should be considered.
No takes yet. Share an insight, caveat, or question.
Chu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: